Resource Center
This section contains international research and may reference indications not approved in all regions. Please consult local approved indications before use.
Filter By:
- Newsletters
We’re excited to share a few key updates from Pulsenmore as we continue to expand our impact in maternal-fetal care. FDA authorization, and what it unlocks Receiving FDA De Novo
- News
Pulsenmore introduces a transformative model for prenatal care - extending ultrasound access beyond the clinic and redefining how we reach and monitor expectant mothers.
- News, Press releases
RAMAT GAN, Israel, Nov. 3, 2025 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted
- News
We are thrilled to announce our collaboration with ARC Innovation and Dr. Avi (Abraham) Tsur, MD),
- News
Feeling your baby move is one of the most reassuring signs during pregnancy - but what happens when an anterior placenta makes that much harder?
- News
What an incredible experience at Royal Australian and New Zealand College of Obstetricians and Gynaecologists RANZCOG 2025!
the news pulse
We invite you to keep up to date with the latest updates by registering to our quarterly newsletter
FAQ